Inhaled glucocorticoids in children: A favourable therapeutic index

Canadian Respiratory Journal

Volumn 6, Issue 2, 1999, Pages 175-178

  Estelle, F ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

Asthma; Beclomethasone dipropionate; Budesonide; Children; Fluticasone propionate; Growth; Inhaled glucocorticoids

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE; PEPTIDOLEUKOTRIENE;

ASTHMA; BRONCHUS HYPERREACTIVITY; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; COUGHING; GROWTH RETARDATION; HOARSENESS; HUMAN; IMMUNOMODULATION; INFANT; INFECTION; INHALATIONAL DRUG ADMINISTRATION; LUNG CLEARANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; SKIN DISEASE; SKINFOLD THICKNESS; SYMPTOMATOLOGY; THROAT DISEASE; THRUSH;

EID: 0033007298     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/957127     Document Type: Short Survey

References (2)

1. Cutz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978;2:407-21.
2. Barnes PJ. Glucocorticoids. In: Kay AB, ed. Allergy and Allergic Diseases. London: Blackwell Science Ltd, 1997:619-41.